Is injection site pain a frequent complaint with Nebido® therapy?
No, injection site pain was reported in less than 3 % of patients during the development of the product and is not different from injections with short-acting testosterone preparations. In the clinical development program, there was no case of drop-out of a patient due to injection pain. In practical use since the broad commercial availability of the product from late 2004 onwards, no major problems were encountered with application site reactions.
